Cross-cultural Adaptation and Validation of the P-CIN for Chinese Pediatric Oncology Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

313 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-05

Study Completion Date

2025-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this study was to conduct a cross-cultural adaptation of the P-CIN into the Chinese context, assess its psychometric properties, and determine the cut-off value of CIPN among Chinese pediatric oncology patients.

Participants provided demographic and clinical characteristics, and complete the translated P-CIN, Wong-baker FACES Pain Rating scale for pain, and Chinese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module for quality of life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cognitive-behavioural Intervention for Anxiety, Depression and Quality of Life Among Children Receiving Chemotherapy.

NCT05270655

Hematologic Malignancy Anxiety Depression +1 more

COMPLETED NA

Symptom Management App for Children at the Early Stage of Cancer Survivorship and Their Caregivers

NCT06015009

Oncology Survivorship

COMPLETED NA

The Effect of Walking Intervention on Sleep Related Symptom Distress in Pediatric Oncology Patients

NCT01742325

Childhood Cancer

UNKNOWN NA

Impact of Cancer on the Physical and Psychological Well-being of Children in Mainland China

NCT02928731

Child

COMPLETED

Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors

NCT07273682

Pediatric Cancer

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A methodological, descriptive study was conducted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pediatric Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Questionnaire

Participants completed the translated P-CIN, Wong-baker FACES Pain Rating scale for pain, and Chinese version of the Pediatric Quality of Life Inventory (PedsQL) Cancer Module for quality of life.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* (1) 6 to 18 years of age
* (2) were diagnosed with cancer
* (3) had received or were currently receiving neurotoxic chemotherapy drugs (e.g., Vincristine, Cisplatin, Carboplatin, Oxaliplatin, Paclitaxel, Docetaxel, Ixabepilone, Bortezomib, Thalidomide)
* (4) were able to communicate, read, and write in Chinese without significant hearing and vision problems to ensure they understood the P-CIN.

Exclusion Criteria

* (1) had a diagnosis of cancer in the central nervous system (CNS) cancer, cancer relapse or secondary cancer
* (2) in the terminal stage
* (3) planned to receive multiple cancer treatment (e.g., radiotherapy and immunotherapy)
* (4) suffered from other neuromuscular diseases (e.g., traumatic brain injury and cerebral palsy)
* (5) had a developmental deficit (e.g., Down's syndrome and other chromosomal disorders)
* (6) have suffered from psychiatric diseases or used antipsychotic drugs
* (7) had peripheral neuropathy symptoms caused by diabetes, genetic diseases, spinal cord injury, or alcoholism, or
* (8) had other neuromuscular disorders (e.g., traumatic brain injury, cerebral palsy).

Minimum Eligible Age

6 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No